Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Epidermolysis Bullosa Simplex”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Looking for participantsNCT07027345
What this trial is testing

A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
BioMendics, LLC 40
Testing effectiveness (Phase 2)Looking for participantsNCT06509984
What this trial is testing

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

Who this might be right for
Epidermolysis Bullosa SimplexGenodermatosis
Centre Hospitalier Universitaire de Nice 20
Large-scale testing (Phase 3)Looking for participantsNCT06073132
What this trial is testing

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

Who this might be right for
Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc. 80
Testing effectiveness (Phase 2)UnknownNCT03016715
What this trial is testing

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplex KobnerWeber-Cockayne Syndrome
Premier Specialists, Australia 8
Testing effectiveness (Phase 2)Study completedNCT02960997
What this trial is testing

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplex KobnerWeber-Cockayne Syndrome
Stanford University 8